Bill Robinson

Mr Robinson was formerly COO of UCB, a Brussels-based global biopharmaceutical company, where as a member of the Executive Committee, he was responsible for their global commercial operations. Previously, Mr Robinson had worked for over 35 years for Eli Lilly, one of the leading US pharmaceutical companies, where he held a number of senior international management roles in Sales and Marketing, General Management, and Research and Development. Prior to his retiring from Lilly he was VP for US Sales and Marketing.

Bill is a former Chairman of Plethora Solutions an AIM-listed UK pharmaceutical company, and a former Board Director of Sciele Pharma, which was a NASDAQ listed company prior to its acquisition by Shionogi.